hepatitis C treatment

New discovery may improve hepatitis C treatment

harminka — Wed, 23 Sep 2009 10:04:00 -0500

Walter and Eliza Hall Institute researchers are part of an international team that has discovered a genetic variation that could identify those people infected with hepatitis C who are most likely to benefit from current treatments.

Hepatitis C therapy causes men's sexual dysfunction

harminka — Tue, 01 Sep 2009 05:02:14 -0500

Sexual impairment is common among men with chronic hepatitis C undergoing antiviral therapy, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

Blueberry leaves to heal Hepatitis

harminka — Fri, 07 Aug 2009 13:06:45 -0500

A chemical found in blueberry leaves has shown a strong effect in blocking the replication of the Hepatitis C virus, opening up a new avenue for treating chronic HCV infections, which affect 200 million people worldwide and can eventually lead to cirrhosis and liver cancer.

New Combination Therapy Helps Hepatitis C Patients

harminka — Wed, 17 Jun 2009 00:30:57 -0500

In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to previous treatment.

HCV Protease Inhibitor Telaprevir Halves Treatment Time for Hepatitis C Patients

harminka — Fri, 05 Jun 2009 12:13:02 -0500

For patients with the most common form of hepatitis C, the addition of a hepatitis C–specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone.

Human genes required for hepatitis C viral replication

harminka — Wed, 18 Mar 2009 12:06:59 -0500

Massachusetts General Hospital (MGH) researchers are investigating a new way to block reproduction of the hepatitis C virus (HCV) – targeting not the virus itself but the human genes the virus exploits in its life cycle.

New therapy for hepatitis C treatment

harminka — Tue, 09 Dec 2008 04:36:22 -0600

Combination therapies similar to those used for HIV patients may be the best way of treating hepatitis C virus (HCV), say researchers from the University of Leeds.

Investigational genotype 1 hepatitis C treatment

harminka — Mon, 03 Nov 2008 10:02:23 -0600

New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection.

Hepatitis C treatment is cost-effective for the US prison population

harminka — Tue, 21 Oct 2008 06:33:46 -0500

Treating all U.S. prisoners who have hepatitis C with the standard therapy of pegylated-interferon and ribavirin would be cost-effective, says a new study in the November issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).

Tibotec begins enrollment for Phase III study of telaprevir

harminka — Wed, 15 Oct 2008 11:34:35 -0500

REALIZE is the first phase III study to evaluate a specifically targeted antiviral therapy for hepatitis C (STAT-C) across a full range of HCV-patients who failed prior treatment to current standard of care, including null responders -

Positive findings in treating patients with advanced hepatitis

harminka — Thu, 24 Apr 2008 10:20:36 -0500

The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed previous interferon-based hepatitis C therapies and have advanced liver disease, according to findings from a large, four-year study presented today at the 43rd annual meeting of the European Association for the Study of the Liver (EASL).

Scientists see Norwalk virus' Achilles heel

harminka — Wed, 19 Mar 2008 08:52:37 -0500

Using the Canadian Light Source synchrotron, an international team led by University of Calgary researcher Ken Ng has determined the detailed structure of the enzyme the Norwalk virus uses to make copies of its genetic code in order to replicate itself. The information is crucial to developing drugs that could be used to treat outbreaks of Norwalk and other related viruses.